We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Greiner Bio-One在Analytica展会上推出创新性化验产品

By LabMedica International staff writers
Posted on 22 May 2014
德国Frickenhausen的Greiner Bio-One公司客户有世界上最大的实验室、生物技术公司和制药公司,它将在2014年5月10–13日于德国慕尼黑举行的analytica 2014展会上推出六款新产品。该公司是诊断行业与制药行业的技术合作商,它正在展示其研发的决心。

Greiner Bio-One公司30年来一直致力于开发低温储藏产品,新型Cryo.s生物库试管的问世扩展了其产品线,现在拥有了在自动化储藏系统里进行高通量样本储藏的解决方案。展会还揭幕了一种新盒子,其规格为标准的133平方毫米,适用于现有的1毫升、2毫升和4毫升Cryo.s冷冻瓶,可容纳81只Cryo.s瓶。盒子底部的开口使扫描仪能够在不移开瓶子的情况下读取二维码。

Greiner Bio-One公司将展示显微镜检领域的两项创新。一个是384孔Screenstar微孔板,可用于高通量高内涵的筛查和高分辨率显微镜检。另一项显微镜检解决方案Cellview玻片是从Cellview产品家族发展出来的。它装备可卸外壳,可将玻片分成十个圆形腔室。取下外壳后,可执行十项独立的细胞培养,以便在一次操作中处理。

在细胞培养领域,Greiner Bio-One公司在Analytica 2014上推出了涂有I型胶原蛋白的新型ThinCert细胞培养插件。天然I型胶原蛋白涂层使生长和分化过程加快了数倍。

为了简化用户的液体处理,Greiner Bio-One公司已经为Sapphire移液管枪头盒开发了新的彩色插件。定制的颜色设计目的是帮助用户更快地辨认某只盒子所装移液管枪头的尺寸。

Greiner Bio-One公司执行董事Heinz Schmid说:“研发对我们这样一家开发驱动型的中型企业来说极为重要。analytica作为化验技术、分析和生物技术领域的顶级展会,是我们向客户和其他感兴趣的各方展示新产品的重要平台。”

Related Links:
Greiner Bio-One
Analytica
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.